TAMPA, Fla., May 12, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced James A. Bianco, M.D., President and Chief...
Hence then, the article about tuhura biosciences to present at the 4th annual h c wainwright bioconnect investor conference was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference )
Also on site :
- Southeast Asia shouldn’t copy the U.S. healthcare model, says Walgreens Boots Alliance’s APAC head: ‘It saves your life, but it’s not very healthy’
- Russian investors win battle over frozen assets
- In 1974, George Harrison Named the One Beatle He’d Happily Form Another Band With — and It Wasn’t Paul McCartney